Abstract
A phase 1/2 clinical trial of systemic gene transfer of scAAV9.U1a.HSGSH for MPS IIIA: Safety, tolerability, and preliminary evidence of biopotency
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have